SCHEMBL24956950

SCHEMBL24956950

c1ccc2c(c1)ccc1c2oc2cccc(-c3ccc(N(c4ccc(-c5cccc6oc7c8ccccc8ccc7c56)cc4)c4ccc(-c5cccc6oc7c8ccccc8ccc7c56)cc4)cc3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 12/20 0.38
▸ CYP1B1 Q16678 12/20 0.38
▸ CYP1A2 P05177 11/20 0.38
▸ TDP1 Q9NUW8 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ PRKDC P78527 3/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ ABCC1 P33527 2/20 0.37
▸ ABCG2 Q9UNQ0 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ ABCB1 P08183 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24957157 0.97 ENPP1 (0.37) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24957154 0.97 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL23308806 0.97 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24194887 0.97 ENPP1 (0.37) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24888784 0.97 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24957277 0.96 CA12 (0.39) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24957354 0.96 TDP1 (0.40) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24194318 0.96 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24956940 0.96 TDP1 (0.40) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1
SCHEMBL24957762 0.96 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795155-B2 Compound having naphthobenzofuranyl structure, material for organic electroluminescence device, organic electroluminescence device, and electronic instrument IDEMITSU KOSAN CO., LTD. (JP) 2023-10-24 — — US disclosed
US-11795155-B2 Compound having naphthobenzofuranyl structure, material for organic electroluminescence device, organic electroluminescence device, and electronic instrument IDEMITSU KOSAN CO., LTD. (JP) 2023-10-24 — — US disclosed
US-20230312501-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-05 — — US disclosed
US-20230312501-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-05 — — US disclosed
WO-2023190597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE 出光興産株式会社 2023-10-05 — — WO disclosed
EP-4242200-A2 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2023-09-13 — — EP disclosed
US-20230026288-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795155-B2 Compound having naphthobenzofuranyl structure, material for organic electroluminescence device, organic electroluminescence device, and electronic instrument L1CAM, LEF1, ARL1 CYP1A1 69/4885CYP1B1 151/4885CYP1A2 533/4885
US-20230312501-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, RER1, L1CAM CYP1A1 1042/4885CYP1B1 2020/4885CYP1A2 1724/4885
US-20230026288-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, RER1, L1CAM CYP1A1 1042/4885CYP1B1 2020/4885CYP1A2 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback